H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodFiling Growth
10 → 18 filings, FY2021 to FY2025 (latest year appears partial)Top Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| Stark Associates LLC | 6 | $74,360 | $67,184 - $102,904 | 100.0% |
| QUAGEN PHARMACEUTICALS | 5 | $95,000 | $65,000 - $96,900 | 100.0% |
| Havix Group LLC | 5 | $49,000 | $37,000 - $52,437 | 100.0% |
| Lohmann Animal Health International Inc. | 4 | $75,000 | $75,000 - $75,000 | 100.0% |
| Garonit Pharmaceuticals | 4 | $65,000 | $65,000 - $65,000 | 50.0% |
| LIBERTY PHARMA INC | 3 | $65,582 | $65,582 - $65,583 | 66.7% |
| DYNAMED CLINICAL RESEARCH | 3 | $68,973 | $65,000 - $68,973 | 66.7% |
| Tailstorm Health, Inc | 2 | $78,302 | $75,234 - $81,370 | 100.0% |
| THE VERITAS HEALTHCARE SOLUTIONS LLC | 2 | $91,572 | $80,517 - $102,627 | 50.0% |
| NOVEL LABORATORIES, INC. | 2 | $63,253 | $58,843 - $67,662 | 50.0% |
| Akston Biosciences Corporation | 2 | $73,550 | $71,100 - $76,000 | 100.0% |
| APNAR PHARMA LLP | 2 | $59,000 | $59,000 - $59,000 | 100.0% |
| INVAGEN PHARMACEUTICALS, INC | 2 | $61,897 | $61,794 - $62,000 | 50.0% |
| BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 2 | $79,850 | $75,000 - $84,699 | 100.0% |
| RK PHARMA INC | 2 | $109,913 | $69,826 - $150,000 | 100.0% |
| City | State | Filings | Median Salary |
|---|---|---|---|
| East Windsor | NJ | 6 | $84,802 |
| Fairfield | NJ | 5 | $65,000 |
| Winslow | ME | 5 | $75,000 |
| Hoschton | GA | 5 | $49,000 |
| West Caldwell | NJ | 4 | $95,000 |
| Chandler | AZ | 3 | $81,370 |
| Houston | TX | 3 | $68,973 |
| LIBERTY | MO | 3 | $65,582 |
| Boston | MA | 2 | $86,750 |
| Kokomo | IN | 2 | $67,184 |
Across the 244,862 petitions we hold for the H-1B cap lottery as a whole, the I-129 filing records the beneficiary's actual pay alongside their country of birth, education and gender. A raw pay gap between two groups is mostly a statement about which jobs they hold — so each gap below is shown twice: as it looks raw, and again measured within the same job title. The second number is the one to read.
Gender is here as the control. Our decomposition of the H-1B gender pay gap found that gap is sorting almost entirely — it survives the correction at under a percent. Country of birth and education do not behave that way: part of each gap is job mix, and a real difference is still standing after the correction.
| Group | Petitions | Median actual pay | Raw gap vs everyone | Within the same job title | Explained by job mix |
|---|---|---|---|---|---|
| India | 164,659 | $90,397 | -$2,288 | -$2,411 | — |
| China | 35,095 | $110,000 | +$17,315 | +$8,896 | 48.6% |
| Philippines | 1,863 | $64,000 | -$28,685 | -$594 | 97.9% |
60 other values (39,441 petitions) are not shown, because too few of their petitions sit in a job title big enough to compare within. Only a raw figure exists there — and a raw figure is the thing this table corrects, so ranking it beside these would mislead rather than inform.
| Group | Petitions | Median actual pay | Raw gap vs everyone | Within the same job title | Explained by job mix |
|---|---|---|---|---|---|
| Master's degree | 102,816 | $91,104 | -$896 | -$262 | — |
| Bachelor's degree | 88,784 | $90,000 | -$2,000 | -$1,219 | 39.0% |
| Doctorate degree | 11,783 | $128,400 | +$36,400 | +$17,739 | 51.3% |
| Professional degree | 2,272 | $150,000 | +$58,000 | +$24,154 | 58.4% |
One other value (103 petitions) is not shown, because too few of its petitions sit in a job title big enough to compare within. Only a raw figure exists there — and a raw figure is the thing this table corrects, so ranking it beside these would mislead rather than inform.
| Group | Petitions | Median actual pay | Raw gap vs everyone | Within the same job title | Explained by job mix |
|---|---|---|---|---|---|
| Men | 164,128 | $93,891 | +$1,206 | -$361 | — |
| Women | 80,734 | $90,000 | -$2,685 | +$469 | — |
How to read this. The within-occupation figure compares people holding the same job title, weighted by how many petitions sit in each title. Titles encode seniority, so equal pay within a title does not rule out differences in reaching that title — the same limitation that applies to any controlled pay-gap number. Figures are base pay only: the I-129 reports prospective base compensation, with no equity or bonus, so this is not total compensation. Coverage is FY2021–FY2024 cap-subject H-1B lottery petitions that carry both a pay figure and a job title — a one-time FOIA snapshot, not a live feed. Aggregates only, with small counts suppressed. Source: I-129 petition data sourced from USCIS, obtained by Bloomberg.
These roles are variations of QUALITY ASSURANCE ASSOCIATE with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| QUALITY ASSURANCE ASSOCIATE | Unspecified | 238 | $63,539 |
| QUALITY ASSURANCE ASSOCIATE MANAGER | 6 | $71,457 | |
| QUALITY ASSURANCE ASSOCIATE DIRECTOR | 4 | $110,803 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 10 | $70,463 | 90.0% |
| 2022 | 12 | $65,000 | 50.0% |
| 2023 | 9 | $80,517 | 77.8% |
| 2024 | 6 | $65,487 | 100.0% |
| 2025 | 18 | $72,904 | 94.4% |
| 2026 | 20 | $75,000 | 95.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| Stark Associates LLC | 6 | $74,360 | 100.0% |
| QUAGEN PHARMACEUTICALS | 5 | $95,000 | 100.0% |
| Havix Group LLC | 5 | $49,000 | 100.0% |
| Lohmann Animal Health International Inc. | 4 | $75,000 | 100.0% |
| Garonit Pharmaceuticals | 4 | $65,000 | 50.0% |